Investor Relations

Press Release

June 4, 2024

Amphastar Announces Additional $50 Million Increase to its Share Buyback Program

More
June 3, 2024

Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

More
May 22, 2024

Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol

More
May 9, 2024

Amphastar Pharmaceuticals to Present at the Bank of America Securities Health Care Conference

More
May 8, 2024

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024

More
April 30, 2024

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024

More
April 1, 2024

Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference

More
March 6, 2024

Amphastar Pharmaceuticals to Present at the Barclays 26th Annual Global Healthcare Conference

More
February 28, 2024

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023

More
February 20, 2024

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2024

More
Youtube